Drawing on his 25 years of experience, Dr. Kwasi Torpe will provide an overview of the origins of Human Immunodeficiency Virus (HIV) as well as the different types of viruses in the Africa region. It would provide an overview of the burden of disease globally and in sub-Saharan Africa. It will outline evidenced based interventions being implemented in several African countries including Ghana, Nigeria, Zambia to address HIV testing gaps, vertical transmission, care and treatment. It will also discuss challenges and opportunities that has shaped HIV program implementation in the Africa region. The presentation will also highlight the importance of key populations and health systems strengthening and how this will contribute to ending HIV/AIDS in Africa. The presentation would also review Africa’s trajectory to reach the 95-95-95 targets and new molecules like long-acting agents and funding to end HIV in Africa.

Drawing on his 25 years of experience, Dr. Kwasi Torpe will provide an overview of the origins of Human Immunodeficiency Virus (HIV) as well as the different types of viruses in the Africa region. It would provide an overview of the burden of disease globally and in sub-Saharan Africa. It will outline evidenced based interventions being implemented in several African countries including Ghana, Nigeria, Zambia to address HIV testing gaps, vertical transmission, care and treatment. It will also discuss challenges and opportunities that has shaped HIV program implementation in the Africa region. The presentation will also highlight the importance of key populations and health systems strengthening and how this will contribute to ending HIV/AIDS in Africa. The presentation would also review Africa’s trajectory to reach the 95-95-95 targets and new molecules like long-acting agents and funding to end HIV in Africa.